Catalent is the #1 CDMO partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people's lives.

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives.

Catalent Cell & Gene Therapy is an industry-leading Contract Development and Manufacturing Organization (CDMO) for advanced therapeutics. Our comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs.

Catalent is your trusted cell therapy CDMO partner for autologous & allogeneic cell therapy development & manufacturing, including CAR-T immunotherapies.

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives.

Your premier biologics CDMO partner to accelerate, simplify and de-risk your next biologic from development through clinical and commercial supply.

In this eBook, learn more about strategies that successful emerging biopharma and biotech companies have used to move their discovery to market.

Catalent is your trusted gene therapy CDMO partner for custom development and scalable manufacturing of adeno-associated virus (AAV) vectors, next-generation vaccines, and oncolytic viruses.

cell therapy cdmo » ipscs. ipscs. overview (gmp ips cells & manipulation platforms; off-the-shelf gmp cell lines; custom ipsc banking & qc; gene editing of ipscs; rpe differentiation of ipscs; cardiac differentiation of ipscs; ipsc-derived mscs; immune cells / ipsc-nk cell platform;

Catalent brings over 85 years of CDMO expertise in product development, delivery, and supply to the global consumer health and beauty markets.